semaglutide aplicacion Aprenda sobre la pluma de Ozempic® Qué dosis semaglutida debo tomar?

19 Lofton H, Ard JD, Hunt RR, Knight MG

Only Wegovy now has the supporting evidence on relevant outcomes, which Novo Nordisk is set to convert into an expanded label and use with payers to broaden coverage

Link: CNBC How Ozempic and Wegovy turned Novo Nordisk into a $400 billion company? (October 11, 2023)

Many have decided not to cover them

The analysis, conducted by researchers from the University of Oxford and supported by the National Institute for Health Research (NIHR) Oxford Health Biomedical Research Centre and the Medical Research Council, revealed that taking the drug, a popular medication for type II diabetes, had no increased risk of adverse neurological or psychiatric outcomes compared to other antidiabetic medications, challenging recent concerns about the drug's safety

Semaglutide linked to increased risk of severe eye condition NAION in new study